Signaturefd LLC lifted its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.4% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,805 shares of the semiconductor company’s stock after purchasing an additional 194 shares during the period. Signaturefd LLC’s holdings in Synopsys were worth $1,951,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in SNPS. GAMMA Investing LLC grew its holdings in Synopsys by 54,286.0% in the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company’s stock valued at $513,116,000 after buying an additional 1,194,292 shares in the last quarter. Nuveen LLC acquired a new position in shares of Synopsys in the first quarter worth about $341,480,000. Pictet Asset Management Holding SA grew its holdings in Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after buying an additional 673,837 shares in the last quarter. Generation Investment Management LLP acquired a new stake in shares of Synopsys during the 1st quarter valued at $240,491,000. Finally, Vanguard Group Inc. increased its position in Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after buying an additional 346,994 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Synopsys
In other news, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the sale, the chief executive officer owned 71,615 shares in the company, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the transaction, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Corporate insiders own 0.62% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Synopsys
Synopsys Stock Performance
Shares of SNPS opened at $487.76 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $90.60 billion, a P/E ratio of 38.29, a price-to-earnings-growth ratio of 5.51 and a beta of 1.14. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The firm’s fifty day simple moving average is $571.71 and its two-hundred day simple moving average is $508.57.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- How to Use the MarketBeat Stock Screener
- 3 Healthcare Stocks Using AI to Drive Growth
- Overbought Stocks Explained: Should You Trade Them?
- Get Exposure to Millennials’ Purchasing Power With This ETF
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why a $4.5 Billion Smart Debt Move Is Fueling Dell’s AI Ambitions
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.